Autres langues MAIA Biotechnology, Inc.

Actions

MAIA

US5526411021

Marché Fermé - Nyse Autres places de cotation 22:00:00 13/06/2024			Varia. 5j.	Varia. 1 janv.
3,79 ^USD	+1,88 %		+14,16 %	+223,93 %

07/06	La fonction de ciblage des télomères de MAIA Biotechnology est démontrée par l'approbation par la FDA d'un agent thérapeutique inhibiteur de la télomérase.	CI
04/06	Maia Biotechnology dévoile de nouvelles données cliniques montrant la forte efficacité de Thio dans le cancer du poumon non à petites cellules	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA?s Approval of a Telomerase Inhibitor Agent Therapy	07/06
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent	06/06
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	06/06
MAIA BIOTECHNOLOGY REVEALS NEW CLINICAL DATA SHOWING THIO'S STRONG EFFICACY IN NON-SMALL CELL LUNG CANCER	05/06
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer	04/06
MAIA Biotechnology : Poster (June 2024)	03/06
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05
MAIA Biotechnology, Inc. announced a financing transaction	21/05
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024	20/05
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING	17/05
MAIA Biotechnology to Present at the BIO International Convention 2024	17/05
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting	16/05
MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement	30/04
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement	29/04
Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	26/04
MAIA Biotechnology Announces $1.00 Million Private Placement	23/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MAIA Biotechnology, Inc.

Actions

MAIA

US5526411021

Autres langues

Filtres